Developer docs
API playgroundTry for free, no card

Search company profiles

Synupse

Full company profile

uuid003iivf

Namestring
Synupse
Legal namestring
Synupse
Websiteurl
synupse.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Synupse is a Tehran, Iran-based healthcare technology startup developing an AI-powered, patient-centered Clinical Decision-Making Support System (CDSS) targeted at orthopedic and broader clinical practice. The platform collects real-time patient data to generate personalized, condition- and lifestyle-specific treatment plans and to coordinate decision-making across multiple medical specialties. The product is grounded in a proprietary patient-centered methodology developed by founder Dr. Hamid Farrokhi, inspired by Cognitive Behavioral Therapy (CBT) methods from psychology and validated through operations at Sepid Orthopedic Clinic, which the same founder established in 2015-2016 as Iran's first patient-centered orthopedic practice.

The platform integrates recommendation and process-automation capabilities to classify diseases and propose treatment pathways based on patient history, examination checklists, lifestyle inputs, and clinical feedback. Synupse operates a hybrid physical-digital model in which Sepid Orthopedic Clinic functions simultaneously as a service provider, an internal deployment, and the primary R&D testing ground for new digital features before any broader commercial release. According to company-reported figures, more than 18,000 patients have been served and more than 7,000 orthopedic diseases studied through the combined platform-clinic operation.

Synupse is bootstrapped and founder-owned, with no disclosed external funding, institutional investors, or revenue figures. Its go-to-market is sales-led and direct, targeting healthcare providers and medical practices primarily in Iran, with marketing concentrated on its website, LinkedIn, and Instagram. Pricing is not publicly disclosed, and the SaaS product is described as being in MVP development as of mid-2022, indicating that commercial traction outside the affiliated clinic has not yet been established.

Short descriptiontext

Synupse develops an AI-powered, patient-centered Clinical Decision Support System (CDSS) for orthopedic and clinical practice, serving healthcare providers primarily in Iran through a hybrid physical-clinic and SaaS platform model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMadrid, Spain
HQ citystring
Madrid
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical decision support, electronic health records, patient-centered care, AI healthcare software, orthopedic treatment planning
Industry2 codes
PRIMARYHLACAGAM
Utilization Management, Appropriateness Criteria & Prior Authorization CDS
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLALAJAD
AI Triage & Clinical Decision Support (CDS) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms
NAICS code2 codes
  • Other Computer Related Services541519
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Healthcare Clinical Decision Support Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Decision Support System Platform
TypeSubscription Recurring
Description

SaaS-based clinical decision support system provided to healthcare providers, functioning as both an electronic health system and innovation in medical care delivery.

synupse.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Synupse develops and sells an AI-powered, patient-centered Clinical Decision-making Support System (CDSS) platform that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative decision-making across multiple medical specialties. The platform functions as both an electronic health system and a clinical decision support tool, with a hybrid physical-digital model anchored by the Sepid Orthopedic Clinic in Tehran, Iran, which serves as R&D testbed and reference customer. Target buyers are healthcare providers and medical practices seeking personalized, data-driven treatment planning.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 18,000+ patients served through the platform and clinic
+2 more records
Product overview1 text field

Synupse offers a single unified product — its AI-powered Clinical Decision-Making Support System (CDSS). The platform serves as a patient-centered solution that combines electronic health record capabilities with intelligent clinical decision support. The system records patient details, learns from patient and medical team data, and generates personalized treatment plans based on individual patient conditions and lifestyles. Patients are involved in every step of the treatment process, with the platform enabling collaborative decision-making across different medical specialties.

Product and service1 record
1Synupse Clinical Decision-Making Support System (CDSS)
CategoryClinical Decision Support Software
Description

An AI-powered, patient-centered Clinical Decision-Making Support System that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative multi-specialty decision-making for healthcare providers. It functions both as an electronic health system and as a clinical decision support tool for personalized treatment planning.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Sepid Orthopedic Clinic
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sepid Orthopedic Clinic, founded by Synupse founder Dr. Hamid Farrokhi in 2016, operates as Iran's first patient-centered orthopedic practice. The clinic serves as Synupse's primary R&D testing ground, where ideas and hypotheses are tested in practical ways before becoming digital products. Sepid team members form a significant portion of Synupse's R&D development team, creating a tight integration between clinical practice and product development.

synupse.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Infermedica provides an AI-based symptom checker and triage/clinical decision support API used by health systems and insurers. It is a direct peer to Synupse because both deploy AI models to convert patient-reported data into clinical decision support outputs for healthcare stakeholders.

TypeEmerging player
Description

Qventus applies AI to hospital operations and clinical workflows, including discharge planning and care pathway optimization. It overlaps with Synupse in using AI to support clinical and operational decision-making, though Qventus focuses on operational rather than treatment-planning decisions.

TypeEmerging player
Description

Health Catalyst provides data, analytics, and decision-support infrastructure to health systems. It is a partial peer because both companies convert clinical and patient data into actionable decision support, though Health Catalyst is a horizontal data/analytics platform rather than a specialty CDSS product.

4K Health
TypeBroad incumbent
Description

K Health combines AI-driven clinical decision support with virtual primary care delivery, using patient data to generate treatment guidance. It overlaps with Synupse on the AI-CDSS layer but operates at a much broader primary-care scale and combines CDS with full telehealth services.

TypeEmerging player
Description

LeanTaas delivers AI-driven decision support for healthcare operations, including scheduling, capacity, and patient flow. It is an adjacent peer because both companies deploy AI to embed decision support into clinical workflows, though LeanTaas is operations-focused while Synupse is treatment-planning focused.

6Babylon Health
TypeDirect peer
Description

Babylon Health built AI-powered clinical decision support and triage tools integrated into telehealth and provider workflows. Synupse shares the AI-CDSS core function of guiding clinical decisions from patient inputs, though Babylon scaled via a global telehealth model rather than a specialty clinic model.

TypeDirect peer
Description

Ada Health offers an AI-powered symptom assessment and clinical decision support platform used by patients and providers. It is directly comparable to Synupse as both build AI-driven CDS tools that translate patient inputs into structured clinical guidance, though Ada operates globally while Synupse is orthopedic-focused.

TypeDirect peer
Description

Mediktor offers an AI-based pre-diagnosis and triage platform used by hospitals, insurers, and telehealth providers. It is comparable to Synupse as another AI-driven clinical decision support layer that takes patient symptom data and produces structured clinical recommendations.

TypeBroad incumbent
Description

UpToDate is the dominant evidence-based clinical decision support reference used by hospitals and clinicians worldwide. It is a broad incumbent competitor to Synupse because it addresses the same physician need for point-of-care clinical guidance, though delivered as expert-authored reference content rather than AI-personalized recommendations.

10Elsevier ClinicalPath (formerly Via Oncology)
TypeBroad incumbent
Description

Elsevier's ClinicalPath and related clinical decision support tools provide evidence-based care pathway guidance to providers. It is comparable to Synupse as another clinical decision support product aiming to standardize and personalize treatment planning across specialties, but at a far larger enterprise scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Synupse

Healthcare Clinical Decision Support Softwaresynupse.com

Synupse develops an AI-powered, patient-centered Clinical Decision Support System (CDSS) for orthopedic and clinical practice, serving healthcare providers primarily in Iran through a hybrid physical-clinic and SaaS platform model.

What Synupse does

Synupse is a Tehran, Iran-based healthcare technology startup developing an AI-powered, patient-centered Clinical Decision-Making Support System (CDSS) targeted at orthopedic and broader clinical practice. The platform collects real-time patient data to generate personalized, condition- and lifestyle-specific treatment plans and to coordinate decision-making across multiple medical specialties. The product is grounded in a proprietary patient-centered methodology developed by founder Dr. Hamid Farrokhi, inspired by Cognitive Behavioral Therapy (CBT) methods from psychology and validated through operations at Sepid Orthopedic Clinic, which the same founder established in 2015-2016 as Iran's first patient-centered orthopedic practice.

The platform integrates recommendation and process-automation capabilities to classify diseases and propose treatment pathways based on patient history, examination checklists, lifestyle inputs, and clinical feedback. Synupse operates a hybrid physical-digital model in which Sepid Orthopedic Clinic functions simultaneously as a service provider, an internal deployment, and the primary R&D testing ground for new digital features before any broader commercial release. According to company-reported figures, more than 18,000 patients have been served and more than 7,000 orthopedic diseases studied through the combined platform-clinic operation.

Synupse is bootstrapped and founder-owned, with no disclosed external funding, institutional investors, or revenue figures. Its go-to-market is sales-led and direct, targeting healthcare providers and medical practices primarily in Iran, with marketing concentrated on its website, LinkedIn, and Instagram. Pricing is not publicly disclosed, and the SaaS product is described as being in MVP development as of mid-2022, indicating that commercial traction outside the affiliated clinic has not yet been established.

Synupse firmographics

Firmographics
Name
Synupse
Legal name
Synupse
Website
https://synupse.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
Synupse develops an AI-powered, patient-centered Clinical Decision Support System (CDSS) for orthopedic and clinical practice, serving healthcare providers primarily in Iran through a hybrid physical-clinic and SaaS platform model.
Ownership category
akta.pro rank

Synupse industry classification

Industry
Product category
Healthcare Clinical Decision Support Software
NAICS
Other Computer Related Services (541519), Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAGAM
Utilization Management, Appropriateness Criteria & Prior Authorization CDS
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLALAJAD
AI Triage & Clinical Decision Support (CDS) Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms

Keywords

  • Clinical decision support
  • Electronic health records
  • Patient-centered care
  • AI healthcare software
  • Orthopedic treatment planning

Where Synupse is headquartered

Location

Headquarters

HQ city
Madrid
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Synupse business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Clinical Decision Support System Platform: SaaS-based clinical decision support system provided to healthcare providers, functioning as both an electronic health system and innovation in medical care delivery.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Synupse product offering

Product offering

Core offering

Synupse develops and sells an AI-powered, patient-centered Clinical Decision-making Support System (CDSS) platform that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative decision-making across multiple medical specialties. The platform functions as both an electronic health system and a clinical decision support tool, with a hybrid physical-digital model anchored by the Sepid Orthopedic Clinic in Tehran, Iran, which serves as R&D testbed and reference customer. Target buyers are healthcare providers and medical practices seeking personalized, data-driven treatment planning.

Product overview

Synupse offers a single unified product — its AI-powered Clinical Decision-Making Support System (CDSS). The platform serves as a patient-centered solution that combines electronic health record capabilities with intelligent clinical decision support. The system records patient details, learns from patient and medical team data, and generates personalized treatment plans based on individual patient conditions and lifestyles. Patients are involved in every step of the treatment process, with the platform enabling collaborative decision-making across different medical specialties.

Differentiator

Problem solved

Functional benefit

Products and services

  • Synupse Clinical Decision-Making Support System (CDSS) An AI-powered, patient-centered Clinical Decision-Making Support System that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative multi-specialty decision-making for healthcare providers. It functions both as an electronic health system and as a clinical decision support tool for personalized treatment planning.

Quantifiable outcome

  • 18,000+ patients served through the platform and clinic
  • +2 more outcomes

Companies that use Synupse

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Synupse technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Synupse partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sepid Orthopedic CliniccoreStrategic or Co-development PartnerSepid Orthopedic Clinic, founded by Synupse founder Dr. Hamid Farrokhi in 2016, operates as Iran's first patient-centered orthopedic practice. The clinic serves as Synupse's primary R&D testing ground, where ideas and hypotheses are tested in practical ways before becoming digital products. Sepid team members form a significant portion of Synupse's R&D development team, creating a tight integration between clinical practice and product development.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Synupse competitors and assessment

Company assessment

Direct peers

  • Infermedica: Infermedica provides an AI-based symptom checker and triage/clinical decision support API used by health systems and insurers. It is a direct peer to Synupse because both deploy AI models to convert patient-reported data into clinical decision support outputs for healthcare stakeholders.
  • Babylon Health: Babylon Health built AI-powered clinical decision support and triage tools integrated into telehealth and provider workflows. Synupse shares the AI-CDSS core function of guiding clinical decisions from patient inputs, though Babylon scaled via a global telehealth model rather than a specialty clinic model.
  • Ada Health: Ada Health offers an AI-powered symptom assessment and clinical decision support platform used by patients and providers. It is directly comparable to Synupse as both build AI-driven CDS tools that translate patient inputs into structured clinical guidance, though Ada operates globally while Synupse is orthopedic-focused.
  • Mediktor: Mediktor offers an AI-based pre-diagnosis and triage platform used by hospitals, insurers, and telehealth providers. It is comparable to Synupse as another AI-driven clinical decision support layer that takes patient symptom data and produces structured clinical recommendations.

Emerging players

  • Qventus: Qventus applies AI to hospital operations and clinical workflows, including discharge planning and care pathway optimization. It overlaps with Synupse in using AI to support clinical and operational decision-making, though Qventus focuses on operational rather than treatment-planning decisions.
  • Health Catalyst: Health Catalyst provides data, analytics, and decision-support infrastructure to health systems. It is a partial peer because both companies convert clinical and patient data into actionable decision support, though Health Catalyst is a horizontal data/analytics platform rather than a specialty CDSS product.
  • LeanTaas: LeanTaas delivers AI-driven decision support for healthcare operations, including scheduling, capacity, and patient flow. It is an adjacent peer because both companies deploy AI to embed decision support into clinical workflows, though LeanTaas is operations-focused while Synupse is treatment-planning focused.

Broad incumbents

  • K Health: K Health combines AI-driven clinical decision support with virtual primary care delivery, using patient data to generate treatment guidance. It overlaps with Synupse on the AI-CDSS layer but operates at a much broader primary-care scale and combines CDS with full telehealth services.
  • Wolters Kluwer UpToDate: UpToDate is the dominant evidence-based clinical decision support reference used by hospitals and clinicians worldwide. It is a broad incumbent competitor to Synupse because it addresses the same physician need for point-of-care clinical guidance, though delivered as expert-authored reference content rather than AI-personalized recommendations.
  • Elsevier ClinicalPath (formerly Via Oncology): Elsevier's ClinicalPath and related clinical decision support tools provide evidence-based care pathway guidance to providers. It is comparable to Synupse as another clinical decision support product aiming to standardize and personalize treatment planning across specialties, but at a far larger enterprise scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Synupse social profiles

Digital presence

Synupse financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Synupse leadership team

Management profile

Number of profiles

Profiles5 records

Synupse subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Synupse funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Synupse M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synupse

What does Synupse do?

Synupse develops and sells an AI-powered, patient-centered Clinical Decision-making Support System (CDSS) platform that collects real-time patient data, classifies disease and treatment plans based on patient condition and lifestyle, and enables collaborative decision-making across multiple medical specialties. The platform functions as both an electronic health system and a clinical decision support tool, with a hybrid physical-digital model anchored by the Sepid Orthopedic Clinic in Tehran, Iran, which serves as R&D testbed and reference customer. Target buyers are healthcare providers and medical practices seeking personalized, data-driven treatment planning.

Is Synupse a public or private company?

Synupse is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Synupse founded?

Synupse was founded in 2010. It employs 1 to 10 people.

Where is Synupse based?

Synupse is headquartered in Madrid, Spain, in the Europe region.

How does Synupse make money?

One revenue line is on record: clinical Decision Support System Platform.

Who are Synupse's main competitors?

Direct peers on record are Infermedica, Babylon Health, Ada Health and Mediktor. Emerging players are Qventus, Health Catalyst and LeanTaas. Broad incumbents are K Health, Wolters Kluwer UpToDate and Elsevier ClinicalPath (formerly Via Oncology).

Does Synupse have an API?

No public API is recorded for Synupse.

What industry is Synupse in?

Synupse's product category is Healthcare Clinical Decision Support Software. Its primary akta.pro industry code is HLACAGAM, Utilization Management, Appropriateness Criteria & Prior Authorization CDS, with a secondary code of HLALAJAD, AI Triage & Clinical Decision Support (CDS) Platforms. Its NAICS code is 541519 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales